Bergan Kdv Wealth Management, LLC Evolus, Inc. Transaction History

Bergan Kdv Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$5.37 - $8.38 $1,476 - $2,304	-275 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$2.92 - $4.84 $58 - $96	-20 Reduced 6.78%	275 $1,000
Q3 2020 Nov 05, 2020	BUY	$3.03 - $5.48 $21 - $38	7 Added 2.43%	295 $1,000
Q1 2020 Apr 24, 2020	BUY	$3.53 - $12.21 $363 - $1,257	103 Added 55.68%	288 $1,000
Q3 2019 Nov 08, 2019	BUY	$13.91 - $19.87 $486 - $695	35 Added 23.33%	185 $3,000
Q2 2019 Aug 12, 2019	BUY	$13.19 - $28.36 $659 - $1,418	50 Added 50.0%	150 $2,000
Q1 2019 May 09, 2019	BUY	$12.43 - $28.91 $1,243 - $2,891	100 New	100 $2,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.